News

Kitron's Q2 Performance: Growth in Defence & Aerospace Sector

Kitron's Q2 Performance: Growth in Defence & Aerospace Sector

Kitron Reports Strong Q2 Performance

In recent developments, Kitron announced noteworthy achievements for the second quarter of 2025, showcasing solid growth sustained by the Defence & Aerospace market. The company's focus on these sectors has catered to a remarkable increase in sales and profitability.

Revenue Insights

For Q2, Kitron achieved a significant revenue total of EUR 172.2 million. This figure represents an increase from EUR 164.6 million in the previous quarter and EUR 167.6 million for the same period last year. The performance indicates the company's robust standing in its core markets, particularly Defence and Aerospace.

Operating Profit Overview

The operating profit for the second quarter stood at EUR 15.0 million, consistent with last year's Q2 profit and up from EUR 12.5 million in Q1 of 2025. The EBIT margin also reflects a positive trend, registering at 8.7%, an increase from 7.6% in the first quarter of this year.

Order Backlog Development

Kitron's order backlog concluded at EUR 509.3 million, showcasing a commendable increase of 12% compared to the same period last year. The orders received signify strong momentum in the Defence and Aerospace sectors while also highlighting growth in the Industrial sector.

CEO Peter Nilsson's Perspective

Peter Nilsson, the CEO of Kitron, expressed his satisfaction with the company's ongoing trajectory. He noted, "With the first half of 2025 completed, I am pleased to report a continued strengthening of our outlook. Sales and profits remain solid, driven by sustained momentum in key sectors. During the second quarter, we secured five strategically important contracts, prompting us to raise our outlook for 2025."

Profit After Tax

Profit after tax for the quarter amounted to EUR 10.0 million, slightly lower than the EUR 10.4 million reported during the same time last year. This outcome corresponds to earnings per share maintaining at EUR 0.05.

Future Outlook for 2025

Looking ahead, Kitron has adjusted its expectations for the full year 2025, now anticipating revenues between EUR 675 million and EUR 725 million. The forecast for operating profit (EBIT) has been escalated to between EUR 55 million and EUR 65 million, an improvement from the previous outlook.

Quarterly Report Highlights

Today, Kitron's interim report presentation transpired, featuring insights from CEO Peter Nilsson and CFO Cathrin Nylander. Notably, interested parties can review the published quarterly report, which encompasses a comprehensive overview of the company’s performance.

Contact Information

Kitron encourages inquiries from stakeholders and interested parties. For more information, individuals can reach out to:

Peter Nilsson, President and CEO, tel. +47 948 40 850

Cathrin Nylander, CFO, tel. +47 900 43 284

Email: investorrelations@kitron.com

About Kitron

As a prominent player in the Nordic region's electronics manufacturing services, Kitron operates across a range of sectors including Connectivity, Electrification, Industry, Medical devices, and Defence/Aerospace. The organization's reach spans multiple countries, showcasing a workforce of approximately 2,400 employees and a remarkable revenue of EUR 647 million in the preceding year.

Frequently Asked Questions

What were Kitron's total revenues for Q2 2025?

Kitron's total revenue for Q2 2025 was EUR 172.2 million, reflecting growth compared to previous quarters.

How much was Kitron's operating profit in Q2?

The operating profit for Kitron in Q2 2025 reached EUR 15.0 million, aligned with the previous year's results.

What does Kitron's order backlog represent?

The order backlog amounted to EUR 509.3 million, representing a 12% growth year-over-year.

What is the updated revenue outlook for Kitron in 2025?

Kitron anticipates full-year revenues between EUR 675 million and EUR 725 million for 2025.

Who can be contacted for more information about Kitron?

Interested parties can reach out to Peter Nilsson or Cathrin Nylander for inquiries about Kitron's performance and outlook.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

PotlatchDeltic Reveals Tax Implications for 2024 Shareholder Dividends

Updated Category News Views 247

PotlatchDeltic Reveals Dividend Tax Treatment for 2024 PotlatchDeltic Corporation (Nasdaq: PCH) is stepping into the spotlight by announcing the tax treatment for its anticipated dividend distributions throughout the year. As a prominent player in the real estate investment sector, this announcement brings clarity to investors regarding how dividends will be categorized...

Continue Reading
Beyond Air Secures $3.25 Million from Warrant Exercises

Updated Category News Views 158

Beyond Air's Strategic Moves to Boost Capital Beyond Air, Inc. (NASDAQ: XAIR), a leading medical device and biopharmaceutical company, is making waves in the financial realm. Focused on the innovative use of nitric oxide (NO) to enhance patient care, Beyond Air has announced the immediate exercise of certain outstanding warrants, aiming to generate approximately $3.25...

Continue Reading
Dr. Sven Kili Joins Saisei Ventures as New Partner

Updated Category News Views 194

Saisei Ventures Welcomes Dr. Sven Kili as Partner Saisei Ventures, a prominent investment firm focused on the advancement of biotechnology and therapeutic innovations, has announced an exciting new chapter in its journey. Dr. Sven Kili, MD, has been appointed as a partner, marking a significant addition to the team's leadership. Dr. Kili, who played an advisory role since...

Continue Reading
MangoRx Unveils Innovative Tirzepatide Tablet for Weight Loss

Updated Category News Views 192

Mangoceuticals, Inc. (NASDAQ: MGRX) launched its new oral Tirzepatide tablet, TRIM, back in 2024 at a steep price of $399 per month. Traders noticed this shift towards a convenient alternative to traditional injectables and were already debating the long-term implications on sales and market share. TRIM's Role: A Game Changer for Weight Management? Tirzepatide has made...

Continue Reading
Mama’s Creations Q2 FY2025 Earnings Call Announcement

Updated Category News Views 77

Mama’s Creations to Host Earnings Call for Second Quarter FY2025 Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, is preparing to announce its financial results for the fiscal second quarter, which ended on July 31. The earnings call is scheduled to take place after the market closes on September 10....

Continue Reading